Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Antibody responses to vaccinia membrane proteins after smallpox vaccination.

Antibody responses to vaccinia membrane proteins after smallpox vaccination. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Antibody responses to vaccinia membrane proteins after smallpox vaccination. Abstract Text:

    steven j lawrenceSteven J Lawrence,kathleen r lottenbachKathleen R Lottenbach,frances k newmanFrances K Newman,r mark l bullerR Mark L Buller,clifford j belloneClifford J Bellone,john j chenJohn J Chen,gary h cohenGary H Cohen,roselyn j eisenbergRoselyn J Eisenberg,robert b belsheRobert B Belshe,samuel l stanleySamuel L Stanley,sharon e freySharon E Frey,

    BACKGROUND: Vaccinia virus (VV) membrane proteins are candidates for orthopoxvirus subunit vaccines and potential targets for therapeutic antibodies. Human antibody responses to these proteins after VV vaccination have not been well characterized. METHODS: Pre- and postvaccination (day 26-30) serum specimens from 80 VV vaccine recipients were examined for immunoglobulin G antibodies specific for B5, A33, A27, and L1 by enzyme-linked immunosorbent assay (ELISA). Responses were compared between vaccinia-naive and previously vaccinated (nonnaive) recipients and between nonnaive recipients of undiluted or 1 : 10 diluted vaccine. RESULTS: VV vaccination elicited anti-A33 and anti-A27 antibodies in nearly all vaccinia-naive subjects (100% and 93%, respectively). Preexisting antibodies were commonly detected in nonnaive subjects (for anti-B5, 68%; for anti-A33, 59%; for anti-A27, 38%; and for anti-L1, 10%). Anti-B5 antibodies were strongly boosted by undiluted vaccine (geometric mean titer [GMT], 151 vs. 1010 for pre- vs. postvaccination; P<.001), whereas anti-L1 antibody responses were less robust (detection rate, 31%; GMT, 75) in nonnaive subjects. Diluted vaccine elicited antibody responses that were similar to those elicited by undiluted vaccine. CONCLUSIONS: Vaccination with VV elicits long-lived specific antibody responses directed against VV membrane proteins that vary by previous vaccination status but not with respect to 10-fold dilution of vaccine. B5, A33, and A27 should be considered for inclusion in future human orthopoxvirus subunit vaccines.

    Antibody responses to vaccinia membrane proteins after smallpox vaccination. Publishing Authors By Initials

    sj lawrenceSJ Lawrence,kr lottenbachKR Lottenbach,fk newmanFK Newman,rm bullerRM Buller,cj belloneCJ Bellone,jj chenJJ Chen,gh cohenGH Cohen,rj eisenbergRJ Eisenberg,rb belsheRB Belshe,sl stanleySL Stanley,se freySE Frey,

    For similar proteins: viral proteins: viral structural proteins: viral envelope proteins research abstracts see: proteins: viral proteins: viral structural proteins: viral envelope proteins research

    PUBMED ID PMID:

    MEDLINE DATE:

    Antibody responses to vaccinia membrane proteins after smallpox vaccination. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of infectious diseases

    VOLUME: 196

    Page Numbers: 220-9

    Journal Abbreviation: J. Infect. Dis.

    ISSN: 0022-1899

    DAY: 4

    MONTH: 06

    YEAR: 2007

    Antibody responses to vaccinia membrane proteins after smallpox vaccination. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 413675

    Antibody responses to vaccinia membrane proteins after smallpox vaccination. Keywords Mesh Terms:

    KEYWORDS: Viral Envelope Proteins

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Antibody responses to vaccinia membrane proteins after smallpox vaccination. Information

    Substance Name: Viral Envelope Proteins

    Registry Number: 0

    Grant and Affiliation Information for Antibody responses to vaccinia membrane proteins after smallpox vaccination.

    AFFILIATION: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. slawrenc@im.wustl.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: U54 AI57168

    ACRONYM: AI

    MEDLINETA: J Infect Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Antibody responses to vaccinia membrane proteins after smallpox vaccination Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News